Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies

BACKGROUND: To investigate, retrospectively, the role of tumour histotype and antiangiogenic drugs for venous thromboembolism (VTE) development in advanced cancer patients treated in phase I studies. METHODS: Patients enrolled and treated in phase I studies conducted by SENDO (Southern Europe New Dr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mandalà, M, Grosso, F, Vitalini, C, Corradino, I, Sanfilippo, R, Colombini, S, Clerici, M, Labianca, R, De Pascale, A, Marsoni, S
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2012
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3419966/
https://ncbi.nlm.nih.gov/pubmed/22828607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.325
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki